Researchers led by the University of Oxford have won a major grant from Diabetes UK to set up the UK's first registry of people at risk of developing type 1 diabetes (T1D) after testing positive for ...

A large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with ...

Please provide your email address to receive an email when new articles are posted on . Trials assessing DPP-IV inhibitors, SGLT2 inhibitors and GLP-1s found no increased CV risk for older adults.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield, Aventis Pharma Limited) as the UK’s first immunotherapy for type 1 diabetes (T1D). The drug is licensed ...

Concerning’ disparities in access to continuous glucose monitors despite black and south Asian people being more likely to live with condition ...